Accrued expenses and other liabilities consist of the following:
September 30,
December 31,
2020
2019
Accrued preclinical and clinical trial expenses
$
627,604
1,156,618
Compensation and related benefits
186,363
303,870
Other expenses
689,932
215,979
1,503,899
1,676,467
No definition available.
Tabular disclosure of the components of accrued liabilities.